These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 22682482)

  • 21. Gastrointestinal complications of cystic fibrosis.
    Gelfond D; Borowitz D
    Clin Gastroenterol Hepatol; 2013 Apr; 11(4):333-42; quiz e30-1. PubMed ID: 23142604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota.
    Fiorotto R; Strazzabosco M
    Cell Mol Gastroenterol Hepatol; 2019; 8(2):197-207. PubMed ID: 31075352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chloride channelopathies.
    Planells-Cases R; Jentsch TJ
    Biochim Biophys Acta; 2009 Mar; 1792(3):173-89. PubMed ID: 19708126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using the genome to correct the ion transport defect in cystic fibrosis.
    Amaral MD
    J Physiol; 2023 May; 601(9):1573-1582. PubMed ID: 36068724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A liposomal platform for the delivery of ion channel proteins for treatment of channelopathies - Application in therapy of cystic fibrosis.
    ElNashar NT; Breitinger U; Breitinger HG; Mansour S; Tammam SN
    Int J Biol Macromol; 2023 Dec; 253(Pt 2):126652. PubMed ID: 37673169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ion channelopathies in functional GI disorders.
    Beyder A; Farrugia G
    Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G581-G586. PubMed ID: 27514480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent Progress in CFTR Interactome Mapping and Its Importance for Cystic Fibrosis.
    Lim SH; Legere EA; Snider J; Stagljar I
    Front Pharmacol; 2017; 8():997. PubMed ID: 29403380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Channelopathies of transepithelial transport and vesicular function.
    Hübner CA; Jentsch TJ
    Adv Genet; 2008; 63():113-152. PubMed ID: 19185187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial vectorial ion transport in cystic fibrosis: Dysfunction, measurement, and pharmacotherapy to target the primary deficit.
    Clunes LA; McMillan-Castanares N; Mehta N; Mesadieu A; Rodriguez J; Maj M; Clunes MT
    SAGE Open Med; 2020; 8():2050312120933807. PubMed ID: 32637102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies to circumvent the CFTR defect in cystic fibrosis.
    Becq F; Chanson M
    Front Pharmacol; 2013; 4():108. PubMed ID: 24009583
    [No Abstract]   [Full Text] [Related]  

  • 31. Cystic fibrosis: Beyond the airways. Report on the meeting of the basic science working group in Loutraki, Greece.
    Amaral MD; Boj SF; Shaw J; Leipziger J; Beekman JM
    J Cyst Fibros; 2018 Jul; 17(4):441-443. PubMed ID: 29866530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ion Channel and Ubiquitin Differential Expression during Erythromycin-Induced Anhidrosis in Foals.
    Patterson Rosa L; Mallicote MF; MacKay RJ; Brooks SA
    Animals (Basel); 2021 Nov; 11(12):. PubMed ID: 34944156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased NF-κB Activity and Decreased Wnt/β-Catenin Signaling Mediate Reduced Osteoblast Differentiation and Function in ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mice.
    Le Henaff C; Mansouri R; Modrowski D; Zarka M; Geoffroy V; Marty C; Tarantino N; Laplantine E; Marie PJ
    J Biol Chem; 2015 Jul; 290(29):18009-18017. PubMed ID: 26060255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective activation of cystic fibrosis transmembrane conductance regulator Cl- and HCO3- conductances.
    Reddy MM; Quinton PM
    JOP; 2001 Jul; 2(4 Suppl):212-8. PubMed ID: 11875262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cystic fibrosis and CFTR.
    Greger R; Schreiber R; Mall M; Wissner A; Hopf A; Briel M; Bleich M; Warth R; Kunzelmann K
    Pflugers Arch; 2001; 443 Suppl 1():S3-7. PubMed ID: 11845294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.
    Stanton BA
    Wien Klin Wochenschr; 1997 Jun; 109(12-13):457-64. PubMed ID: 9261986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
    Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M
    Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macromolecular complexes of cystic fibrosis transmembrane conductance regulator and its interacting partners.
    Li C; Naren AP
    Pharmacol Ther; 2005 Nov; 108(2):208-23. PubMed ID: 15936089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cystic fibrosis and other channelopathies].
    Edelman A; Saussereau E
    Arch Pediatr; 2012 May; 19 Suppl 1():S13-6. PubMed ID: 22682482
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.